Kingston University London

QMI³

Quantitative Medical Imaging International Institute

The Quantitative Medical Imaging International Institute (QMI³) brings together a number of organisations and their current research and development in the field of medical imaging, integrating this research with clinical expertise and practice. QMI³ is based at Kingston University and headed by Professor Jamshid Dehmeshki.

The QMI³ project brings together under a single umbrella researchers from across the globe, who engaged in the development of medical image analysis algorithms and medical imaging instrumentation, with clinical staff involved in the diagnostic and therapeutic application of medical imaging technology.

QMI³ aims to increase the visibility of medical imaging related research, to exploit synergies between different research activities and to build a critical mass of researchers able to attract higher levels of funding and industrial collaboration. QMI³ will also provide a pathway for the commercial exploitation of its medical imaging research.

Partnerships

QMI³ has already established a network of partnerships in medical engineering and the health sector across the UK and overseas

Projects

Quantitative Imaging Lab (QIL)

Our first project is a collaboration with the University Hospital of Lausanne (CHUV).

The Quantitative Imaging Lab (QIL) has been established to research and develop novel vascular medical image analysis algorithms and software and to validate their effectiveness in a clinical environment.

A team based at Kingston University, under the direction of Professor Jamshid Dehmeshki, is undertaking research and developing new techniques that automate the analysis of 3D vascular medical images. These techniques are applied to high resolution image datasets generated by whole-body scanning technologies such as computer-aided tomography (CAT) and magnetic resonance imaging (MRI).

A team based in the Radiology Department at CHUV, under the direction of Professor Salah Qanadli, evaluates the algorithms and software developed by the Kingston team and investigates their efficacy in both diagnostic and therapeutic contexts. The two teams work together to develop accurate, innovative solutions.

The QIL Project and outputs:

• AAA: Abdominal Aortic Aneurysm
• TAA: Thoracic Aortic Aneurysm
• BA: Brain Aneurysm
• CAD: Coronary Artery Disease
• PAD: Peripheral Arterial Disease
• PE: Pulmonary Embolism
• RVD: Atherosclerotic Reno Vascular Disease